SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-021801
Filing Date
2022-06-10
Accepted
2022-06-10 07:30:10
Documents
1
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4003
  Complete submission text file 0000899243-22-021801.txt   5711
Mailing Address C/O AFFYMAX, INC. 4001 MIRANDA AVE. PALO ALTO CA 94304
Business Address
Morris Arlene (Reporting) CIK: 0001362520 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36483 | Film No.: 221007630

Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories